Literature DB >> 17604256

Synthetic and pharmacological studies on longicalycinin A.

Rajiv Dahiya1.   

Abstract

Present investigation describes the synthesis of a natural phenylalanine-rich cyclopolypeptide longicalycinin A (10) by coupling of dipeptide unit Boc-L-phe-L-tyr-OH with tripeptide unit L-pro-L-phe-gly-OMe followed by cyclization of linear segment. Synthesized cyclic pentapeptide was characterized by spectral techniques including FTIR, 1H/13C NMR, FAB MS and elemental analysis and screened for different pharmacological activities. It was found that it has good anthelmintic activity against Megascoplex konkanensis, Pontoscotex corethruses and Eudrilus sp. at 2 mg/ml concentration, in addition to high cytotoxicity against Dalton's lymphoma ascites (DLA) and Ehrlich's ascites carcinoma (EAC) cell lines with CTC50 values of 2.62 and 6.37 microM. Dermatophytes were found to be moderately sensitive towards newly synthesized peptide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604256

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  11 in total

1.  Total synthesis and antimicrobial activity of a natural cycloheptapeptide of marine origin.

Authors:  Rajiv Dahiya; Hemendra Gautam
Journal:  Mar Drugs       Date:  2010-08-19       Impact factor: 5.118

2.  Synthetic and biological studies on a cyclopolypeptide of plant origin.

Authors:  Rajiv Dahiya; Akhilesh Kumar
Journal:  J Zhejiang Univ Sci B       Date:  2008-05       Impact factor: 3.066

3.  Synthesis of Tripeptide Derivatives with Three Stereogenic Centers and Chiral Recognition Probed by Tetraaza Macrocyclic Chiral Solvating Agents Derived from d-Phenylalanine and (1 S,2 S)-(+)-1,2-Diaminocyclohexane via 1H NMR Spectroscopy.

Authors:  Lei Feng; Guangpeng Gao; Hongmei Zhao; Li Zheng; Yu Wang; Pericles Stavropoulos; Lin Ai; Jiaxin Zhang
Journal:  J Org Chem       Date:  2018-10-30       Impact factor: 4.354

4.  Toward the synthesis and biological screening of a cyclotetrapeptide from marine bacteria.

Authors:  Rajiv Dahiya; Hemendra Gautam
Journal:  Mar Drugs       Date:  2010-12-30       Impact factor: 5.118

5.  First Total Synthesis and Biological Screening of a Proline-Rich Cyclopeptide from a Caribbean Marine Sponge.

Authors:  Rajiv Dahiya; Sunil Singh; Ajay Sharma; Suresh V Chennupati; Sandeep Maharaj
Journal:  Mar Drugs       Date:  2016-12-15       Impact factor: 5.118

Review 6.  Natural Proline-Rich Cyclopolypeptides from Marine Organisms: Chemistry, Synthetic Methodologies and Biological Status.

Authors:  Wan-Yin Fang; Rajiv Dahiya; Hua-Li Qin; Rita Mourya; Sandeep Maharaj
Journal:  Mar Drugs       Date:  2016-10-26       Impact factor: 5.118

Review 7.  Natural Bioactive Thiazole-Based Peptides from Marine Resources: Structural and Pharmacological Aspects.

Authors:  Rajiv Dahiya; Sunita Dahiya; Neeraj Kumar Fuloria; Suresh Kumar; Rita Mourya; Suresh V Chennupati; Satish Jankie; Hemendra Gautam; Sunil Singh; Sanjay Kumar Karan; Sandeep Maharaj; Shivkanya Fuloria; Jyoti Shrivastava; Alka Agarwal; Shamjeet Singh; Awadh Kishor; Gunjan Jadon; Ajay Sharma
Journal:  Mar Drugs       Date:  2020-06-24       Impact factor: 5.118

8.  Total Synthesis and Pharmacological Investigation of Cordyheptapeptide A.

Authors:  Suresh Kumar; Rajiv Dahiya; Sukhbir Lal Khokra; Rita Mourya; Suresh V Chennupati; Sandeep Maharaj
Journal:  Molecules       Date:  2017-05-27       Impact factor: 4.411

Review 9.  Cancer Treatment by Caryophyllaceae-Type Cyclopeptides.

Authors:  Mohammad Hassan Houshdar Tehrani; Mohammadreza Gholibeikian; Abdolhamid Bamoniri; Bi Bi Fatemeh Mirjalili
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-14       Impact factor: 5.555

10.  Discrimination of enantiomers of amides with two stereogenic centers enabled by chiral bisthiourea derivatives using 1H NMR spectroscopy.

Authors:  Hanchang Zhang; Hongmei Zhao; Jie Wen; Zhanbin Zhang; Pericles Stavropoulos; Yanlin Li; Lin Ai; Jiaxin Zhang
Journal:  Org Biomol Chem       Date:  2021-08-05       Impact factor: 3.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.